369 related articles for article (PubMed ID: 17948283)
1. Lung disease severity, chronic inflammation, iron deficiency, and erythropoietin response in adults with cystic fibrosis.
Fischer R; Simmerlein R; Huber RM; Schiffl H; Lang SM
Pediatr Pulmonol; 2007 Dec; 42(12):1193-7. PubMed ID: 17948283
[TBL] [Abstract][Full Text] [Related]
2. Anemia in cystic fibrosis: incidence, mechanisms, and association with pulmonary function and vitamin deficiency.
von Drygalski A; Biller J
Nutr Clin Pract; 2008; 23(5):557-63. PubMed ID: 18849562
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease.
Vizza CD; Letizia C; Sciomer S; Naeije R; Della Rocca G; Di Roma A; Musarò S; Quattrucci S; Gaudio C; Battagliese A; Badagliacca R; D'Erasmo E; Fedele F
Regul Pept; 2005 Jan; 124(1-3):187-93. PubMed ID: 15544858
[TBL] [Abstract][Full Text] [Related]
4. Relative anemia and iron deficiency in cystic fibrosis.
Ater JL; Herbst JJ; Landaw SA; O'Brien RT
Pediatrics; 1983 May; 71(5):810-4. PubMed ID: 6835767
[TBL] [Abstract][Full Text] [Related]
5. Distortion of iron status indices by acute inflammation in older hospitalized patients.
Cunietti E; Chiari MM; Monti M; Engaddi I; Berlusconi A; Neri MC; De Luca P
Arch Gerontol Geriatr; 2004; 39(1):35-42. PubMed ID: 15158579
[TBL] [Abstract][Full Text] [Related]
6. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
Mircescu G; Gârneata L; Capusa C; Ursea N
Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
[TBL] [Abstract][Full Text] [Related]
7. Anemia and erythropoietin levels in lung transplant recipients.
End A; Stift A; Wieselthaler G; Griesmacher A; Schlechta B; Koppensteiner R; Schreiner W; Geissler K; Stockenhuber F; Klepetko W
Transplantation; 1995 Dec; 60(11):1245-51. PubMed ID: 8525518
[TBL] [Abstract][Full Text] [Related]
8. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
9. Role of C-reactive protein, reticulocyte haemoglobin content and inflammatory markers in iron and erythropoietin administration in dialysis patients.
El-Khatib M; Duncan HJ; Kant KS
Nephrology (Carlton); 2006 Oct; 11(5):400-4. PubMed ID: 17014552
[TBL] [Abstract][Full Text] [Related]
10. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
Karadag F; Kirdar S; Karul AB; Ceylan E
Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
[TBL] [Abstract][Full Text] [Related]
11. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
[TBL] [Abstract][Full Text] [Related]
13. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
Gentil MA; Pérez-Valdivia MA; López-Mendoza M; Ortega F; Arias M; Gómez-Alamillo C; Campistol JM;
Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
[TBL] [Abstract][Full Text] [Related]
14. Anemia following renal transplantation: erythropoietin response and iron deficiency.
Miles AM; Markell MS; Daskalakis P; Sumrani NB; Hong J; Sommer BG; Friedman EA
Clin Transplant; 1997 Aug; 11(4):313-5. PubMed ID: 9267720
[TBL] [Abstract][Full Text] [Related]
15. [High prevalence of osteoporosis in adult cystic fibrosis patients].
Lang SM; Fischer R; Stratakis DF; Huber RM
Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1551-5. PubMed ID: 15243902
[TBL] [Abstract][Full Text] [Related]
16. Iron deficiency in the acute-phase reaction after open aortic surgery.
Solis JV; Portero JL; Diaz J; Garcia R; Ligero JM; Vazquez E; Lodeiro C; Ballesteros L
Vasc Endovascular Surg; 2006; 40(5):392-8. PubMed ID: 17038573
[TBL] [Abstract][Full Text] [Related]
17. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
Tagboto S; Cropper L; Mostafa S; Turner J; Bailey G; Pugh-Clarke K
J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076
[TBL] [Abstract][Full Text] [Related]
18. Vitamin A levels in patients with CF are influenced by the inflammatory response.
Greer RM; Buntain HM; Lewindon PJ; Wainwright CE; Potter JM; Wong JC; Francis PW; Batch JA; Bell SC
J Cyst Fibros; 2004 Aug; 3(3):143-9. PubMed ID: 15463900
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
Latzin P; Fehling M; Bauernfeind A; Reinhardt D; Kappler M; Griese M
J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
[TBL] [Abstract][Full Text] [Related]
20. Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis.
Bateman AP; McArdle F; Walsh TS
Crit Care Med; 2009 Jun; 37(6):1906-12. PubMed ID: 19384207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
